Simon Glerup PhD

Simon Glerup is an Associate Professor at Aarhus University and co-founder of Draupnir Bio. He was the CEO of Draupnir from its incorporation through the Seed and Series A financing rounds, and led the process of building the organization and recruiting the management team. With the onboarding of Andrew Hotchkiss as CEO, Simon transitioned to CSO and continues on the board of directors. Before the founding of Draupnir Bio, Simon had led research teams at Aarhus University and Mayo Clinic, pioneering the understanding of the structure, function, and physiology of the sortilin-related receptor family.

Simon and his university colleagues also founded Muna Therapeutics and Teitur Trophics, developing treatments for neurological disorders. Simon holds a PhD in Molecular Biology from Aarhus University. He is the recipient of several grants and awards, including the Sapere Aude Research Leader Award in 2015 and the Skou Prize in 2017. He has served as a board member of the Danish Society for Neuroscience from 2015 to 2019 and is currently a member of the Novo Nordisk Foundation Innovation Committee.